The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema
The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema
Recruiting · NCT06655428 · Registry updated 2025-01-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, pulmonary emphysema, respiratory system disorder | Recruiting | Not applicable | 2025-01-28 | NCT06655428 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Morair Medtech, LLC | 1 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asklepios Klinik Barmbek | Hamburg | Germany | 2 |
| Asklepios Lungenklinik Gauting GmbH | Gauting | Germany | 1 |
| Gemeinschaftskrankenhaus Havelhöhe gGmbH Klinik für Anthroposophische Medizin | Berlin | Germany | 1 |
| Klinik Floridsdorf | Vienna | Austria | 1 |
| Thoraxklinik University of Heidelberg | Heidelberg | Germany | 1 |
| University Medical Center Groningen | Groningen | Netherlands | 1 |
| Universitätsklinikum Allgemeines Krankenhaus Wien | Vienna | Austria | 1 |